≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Henoch-Schönlein purpura nephritis (HSPN)

Endpoint Browser PheWeb

N14_HENOCHSCHONLEIN_NEPHRITIS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

130

4. Check minimum number of events

None

130

5. Include endpoints

None

130

6. Filter based on genotype QC (FinnGen only)

130

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1118 469 646
Only index persons 1031 442 589
Unadjusted period prevalence (%)
Whole population 0.02 0.01 0.02
Only index persons 0.02 0.02 0.02
Median age at first event (years)
Whole population 22.53 20.27 24.01
Only index persons 23.01 21.65 24.04

-FinnGen-

Key figures

All Female Male
Number of individuals 130 66 64
Unadjusted period prevalence (%) 0.03 0.02 0.03
Median age at first event (years) 43.22 33.18 53.56

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
118
Matched controls
1179
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
+∞
159.4
114
*
D69.0
ICD-10 Finland
Allergic purpura
684.4
87.3
76
*
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
60.8
53
*
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
+∞
52.0
46
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
71.5
35.2
39
8
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
267.6
22.4
22
*
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
+∞
20.4
19
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
42.5
19.8
24
7
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
10.9
18.8
38
49
N18.8
ICD-10 Finland
Other chronic renal failure
40.3
18.8
23
7
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
79.4
18.4
20
*
TK800
NOMESCO Finland
Hemodialysis
50.4
18.0
21
5
Z49.1
ICD-10 Finland
Extracorporeal dialysis
105.3
17.1
18
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
36.0
16.8
21
7
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.7
16.7
43
82
H02AB06
ATC
prednisolone; systemic
5.3
16.2
81
343
A12AA04
ATC
calcium carbonate; oral
52.6
15.6
18
*
A11CC03
ATC
alfacalcidol; systemic
37.3
15.3
19
6
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.7
14.3
73
301
KA1AE
NOMESCO Finland
Kidney ultrasound examination
17.9
13.7
21
14
Z94.0
ICD-10 Finland
Kidney transplant status
78.6
12.9
14
*
B03XA02
ATC
darbepoetin alfa; parenteral
34.0
12.0
15
5
L04AA06
ATC
mycophenolic acid; systemic
26.1
11.9
16
7
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.4
11.9
53
183
C03CA01
ATC
furosemide; systemic
4.8
11.9
46
138
205
Kela drug reimbursment
Chronic hypertension
4.8
11.9
46
138
M36.4*D69.0
ICD-10 Finland
Arthropathy in Henoch(-Schönlein) purpura
+∞
11.6
11
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
11.0
11.6
22
24
V03AE01
ATC
polystyrene sulfonate; oral
48.3
11.2
13
*
127
Kela drug reimbursment
Transplant complication
31.4
11.0
14
5
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
120.3
10.6
11
*
C09CA01
ATC
losartan; oral
4.7
10.6
41
121
V03AE02
ATC
sevelamer; oral
+∞
10.6
10
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
44.2
10.2
12
*
L04AD01
ATC
ciclosporin; systemic
22.4
10.1
14
7
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.6
10.0
19
21
H02AB04
ATC
methylprednisolone; systemic
5.2
9.2
30
73
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
40.0
9.2
11
*
C09AA02
ATC
enalapril; systemic
4.3
9.0
37
114
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.8
8.8
31
82
M10.9
ICD-10 Finland
Gout, unspecified
9.0
8.8
18
23
R31
ICD-10 Finland
Unspecified haematuria
5.8
8.7
25
52
137
Kela drug reimbursment
Uraemia requiring dialysis
30.0
8.6
11
*
B03XA01
ATC
erythropoietin; parenteral
96.7
8.5
9
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
96.7
8.5
9
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
+∞
8.4
8
*
H05BX01
ATC
cinacalcet; oral
+∞
8.4
8
*
L95.8
ICD-10 Finland
Other vasculitis limited to skin
+∞
8.4
8
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
16.0
8.4
13
9
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.7
8.3
21
37
L04AA01
ATC
[U] ciclosporin; systemic
18.9
8.3
12
7
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
48.2
7.8
9
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
48.2
7.8
9
*
C08CA01
ATC
amlodipine; oral
3.3
7.7
49
209
L04AX01
ATC
azathioprine; systemic
7.1
7.6
18
29
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
14.7
7.6
12
9
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
85.2
7.5
8
*
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
32.2
7.3
9
*
B05DA
ATC
Isotonic solutions
32.2
7.3
9
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.6
7.1
34
118
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
10.3
7.0
13
14
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
42.6
6.8
8
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
42.6
6.8
8
*
TK820
NOMESCO Finland
Peritoneal dialysis
42.6
6.8
8
*
Z49.2
ICD-10 Finland
Other dialysis
24.1
6.8
9
*
V03AE03
ATC
lanthanum carbonate; oral
73.7
6.5
7
*
C07AB02
ATC
metoprolol; systemic
3.8
6.4
28
90
C07AG02
ATC
carvedilol; oral
8.4
6.3
13
17
M05BA04
ATC
alendronic acid; oral
8.0
6.1
13
18
E0000UV
ATC
NA
2.7
6.0
55
289

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
84
114
19.00
67.42
17.8
6.7
mmol/l
1.2
1.1
2.92
79
104
(3012516) Albumin [Mass/volume] in Urine
93
238
11.22
41.46
9.0
3.2
mg/l
228.4
74.4
2.59
86
153
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
102
346
10.04
32.73
11.4
3.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
33
32
13.48
31.11
10.1
3.1
g/l
0.4
0.3
0.63
25
16
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
53
114
7.16
25.94
7.3
2.1
%
23.9
22.6
0.24
45
97
(3017817) Protein [Mass] in Urine collected for unspecified duration
28
9
39.10
22.60
3.0
5.0
—
—
—
0
0
(3012544) pH of Venous blood
44
95
6.49
21.03
11.6
3.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
43
93
6.41
20.47
11.8
3.2
mmol/l
1.0
1.7
0.72
37
72
(3002582) Erythrocytes [#/volume] in Urine
81
305
5.39
20.30
10.7
2.9
e6/l
58.6
242.4
0.42
73
239
(3000991) Gas panel - Venous blood
39
80
6.54
19.52
13.3
8.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
75
276
5.06
19.06
10.2
2.7
e6/l
0.1
0.4
1.92
67
208
(3037522) Nuclear Ab [Titer] in Serum
50
132
5.53
19.03
1.6
1.4
titre
884.4
340.7
—
9
29
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
97
441
5.73
18.79
25.8
7.9
mmol/l
1.2
1.2
0.06
83
367
(36304419) Bacteria [Presence] in Urine
73
274
4.80
17.82
9.3
2.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
83
350
4.79
17.23
12.2
3.3
e6/l
82.8
52.4
0.18
74
248
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
30
55
6.79
16.61
8.8
3.4
mmol/l
0.8
1.1
0.14
22
42
(42870588) Differential panel, method unspecified - Blood
79
331
4.53
16.30
8.4
5.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
25
39
7.70
16.02
1.5
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
26
43
7.31
15.81
1.3
2.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
25
41
7.31
15.30
10.7
3.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
67
262
4.21
14.90
17.3
4.2
ph
7.4
7.4
0.92
15
45
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
49
156
4.44
14.34
6.6
2.3
e6/l
0.9
1.1
0.13
38
91
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
138
4.46
13.77
7.3
2.5
e6/l
3.9
2.3
0.33
33
75
(3006315) Basophils [#/volume] in Blood
98
527
4.49
13.34
9.3
5.3
e9/l
0.0
0.0
0.27
93
472
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
64
5.30
12.14
4.1
2.7
ml/min/173m2
56.2
80.4
1.87
18
27
(3019198) Lymphocytes [#/volume] in Blood
98
552
4.15
11.89
9.4
5.3
e9/l
1.9
2.0
0.45
92
501
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
16
23
7.79
10.83
3.1
1.2
u/ml
124.6
100.6
—
7
7
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
23
7.79
10.83
2.5
2.4
u/ml
0.3
0.3
—
7
14
(3023368) Bacteria identified in Blood by Culture
59
252
3.46
10.80
7.2
4.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
10
11.92
10.30
1.4
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
72
355
3.30
10.30
9.1
6.8
inr
1.3
1.2
0.27
18
110
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14
19
8.14
9.90
1.6
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
0
+∞
9.48
6.7
0.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
27
6.62
9.37
2.9
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
23
56
4.78
9.16
10.0
4.1
g/l
118.8
128.7
0.93
23
56
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
16
28
6.38
9.04
1.4
1.3
u/ml
154.8
195.1
0.65
11
16
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
54
239
3.15
9.03
3.0
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
18
7.91
9.02
1.4
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
38
137
3.51
8.87
2.7
2.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
88
518
3.16
8.79
9.2
3.3
estimate
0.0
0.0
0.00
21
99
(3037467) Urinalysis macro (dipstick) panel - Urine
107
708
3.89
8.76
13.0
3.8
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
12
16
8.16
8.56
1.8
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
28
84
3.97
8.52
8.6
3.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
88
525
3.09
8.45
9.5
3.3
estimate
0.0
0.0
0.00
23
95
(3021601) Nitrite [Presence] in Urine by Test strip
87
516
3.07
8.44
12.6
4.4
estimate
0.0
0.0
0.00
23
100
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
30
5.94
8.44
1.4
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
98
634
3.22
7.91
10.5
8.5
e9/l
5.2
4.1
4.95
93
557
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
24
69
4.04
7.70
8.5
6.6
mmol/l
23.3
25.1
1.76
24
69
(3019230) Fractional oxyhemoglobin in Venous blood
11
15
7.92
7.67
7.2
2.3
%
82.4
76.4
0.82
11
15
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
9
14.52
7.55
11.7
3.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
26
5.91
7.43
1.2
2.1
g/l
4.1
3.7
—
9
20
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
26
5.91
7.43
1.2
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
42
183
2.91
6.98
3.4
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
5
19.16
6.36
1.1
7.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
0
+∞
6.29
1.0
0.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
11
19
6.23
6.22
8.3
2.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
31
4.94
6.15
1.3
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
27
5.24
6.12
1.5
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
116
3.06
6.08
1.5
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
88
583
2.58
5.98
8.9
5.7
mmol/l
6.6
6.5
0.02
83
535
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
81
517
2.50
5.96
5.4
6.4
umol/l
11.6
10.6
0.13
75
496
(46235355) HIV 1 and 2 tests - Meaningful Use set
55
295
2.50
5.91
3.1
2.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
20
5.92
5.91
7.0
4.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
9
11.91
5.90
1.4
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
69
411
2.45
5.89
9.3
3.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
17
46
4.10
5.86
11.6
4.1
mmol/l
23.8
24.4
0.34
17
46
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
25
90
3.20
5.69
4.1
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
73
454
2.39
5.56
16.0
8.2
e9/l
0.0
0.0
0.62
58
367
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
17
48
3.92
5.54
8.6
2.7
%
1.1
1.3
0.59
17
48
(3019550) Sodium [Moles/volume] in Serum or Plasma
124
1045
5.04
5.42
42.6
14.3
mmol/l
139.0
139.6
1.79
124
1017
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
8
11.97
5.38
1.8
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
8
11.97
5.38
2.9
2.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
76
3.28
5.34
2.5
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
112
2.91
5.32
2.2
1.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
0
+∞
5.24
11.6
0.0
mmol/l
5.5
—
—
5
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
124
1053
4.84
5.24
43.6
14.3
mmol/l
4.1
4.0
2.50
124
1022
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
107
2.92
5.21
2.2
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
6
14.08
5.15
1.5
6.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
52
288
2.34
5.06
8.0
3.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
49
266
2.35
4.98
9.1
6.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
48
262
2.32
4.79
5.0
2.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
33
153
2.55
4.70
2.2
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
102
769
2.52
4.59
6.9
3.6
mm/h
19.6
10.1
5.38
96
710
(3019060) Gas panel - Arterial blood
19
66
3.20
4.56
3.9
11.8
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
25
104
2.74
4.39
7.6
13.1
kpa
12.6
11.8
0.20
25
98
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
25
104
2.74
4.39
7.7
13.1
kpa
4.7
5.0
0.77
25
96
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
12
31
4.16
4.36
1.6
1.8
%
105.1
94.0
0.95
12
31
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
41
217
2.30
4.34
3.4
3.2
ng/l
1907.1
1197.3
0.57
33
181
(3007853) Bacteria identified in Skin by Aerobe culture
26
111
2.68
4.34
2.6
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
6
12.23
4.32
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
41
3.71
4.32
2.4
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
43
233
2.26
4.30
3.3
2.0
mg/l
2.6
2.9
0.64
38
195
(3007164) IgA [Mass/volume] in Serum or Plasma
47
265
2.21
4.27
1.6
1.3
g/l
3.3
2.3
3.86
38
158
(3016502) Oxygen saturation in Arterial blood
23
95
2.73
4.08
7.9
14.2
%
96.1
96.0
0.03
23
90
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
59
3.16
4.08
1.6
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
11
29
4.05
3.89
1.8
2.2
%
296.1
167.9
1.89
11
29
(3029937) Albumin [Presence] in Urine by Test strip
49
290
2.11
3.88
10.0
3.7
estimate
0.0
0.0
0.49
17
94
(3003396) Base excess in Arterial blood by calculation
24
104
2.60
3.88
7.9
13.4
mmol/l
-1.5
1.1
1.18
16
78
(3011397) Hemoglobin [Presence] in Urine by Test strip
43
243
2.15
3.83
8.5
3.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
53
327
2.05
3.73
2.2
1.9
pmol/l
88.7
92.2
0.20
30
175
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
30
3.91
3.72
1.4
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
114
940
2.73
3.66
27.1
11.6
ml/min/173m2
69.7
88.7
6.28
102
750
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
18
69
2.87
3.65
18.6
3.7
mmol/l
1.2
1.2
0.84
18
58
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
20
82
2.70
3.59
2.1
2.9
g/l
0.2
0.2
1.32
20
75
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
123
1083
3.52
3.48
34.5
12.8
mg/l
22.8
23.6
0.11
117
828
(3044640) Blood type and Crossmatch panel - Blood
51
317
2.00
3.47
3.6
2.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
18
71
2.78
3.47
3.3
4.1
%
0.1
0.1
—
7
25
(3049717) Cytology report of Urine Cyto stain
11
32
3.66
3.41
3.2
2.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
19
78
2.68
3.40
3.2
3.9
%
0.4
0.7
—
7
28
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
40
231
2.06
3.31
3.4
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
15
5.60
3.24
1.0
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
69
484
1.91
3.24
4.9
4.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
56
367
1.92
3.23
4.1
3.0
u/l
29.0
29.9
0.16
51
348
(3021901) Oxygen saturation in Capillary blood
7
11
6.65
3.23
4.3
3.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
17
68
2.73
3.19
3.1
4.1
%
0.0
0.4
—
6
21
(3019225) pH of Specimen
17
68
2.73
3.19
16.7
4.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
9
20
4.75
3.17
8.9
2.3
kpa
5.2
5.1
—
9
20
(40760892) CBC W Ordered Manual Differential panel - Blood
41
243
2.00
3.15
7.0
4.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
29
3.65
3.11
1.4
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
5
5
10.32
3.00
1.4
1.2
—
—
—
0
0
(44790049)
8
17
4.94
2.97
1.0
1.5
—
—
—
0
0
(44790047)
8
17
4.94
2.97
1.0
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
17
4.94
2.97
2.0
2.7
—
—
—
0
0
(44806118)
8
17
4.94
2.97
1.0
1.5
—
—
—
0
0
(44790048)
8
17
4.94
2.97
1.0
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
13
5.62
2.91
7.9
3.4
%
54.9
54.9
—
7
13
(3011648) Oxygen content in Venous blood
7
13
5.62
2.91
4.6
2.2
%
11.9
13.7
—
7
13
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
13
5.62
2.91
7.6
3.2
e9/l
4.3
3.5
—
7
13
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
6
9
6.92
2.90
1.3
1.3
u/l
118.2
203.1
—
6
9
(40761511) CBC panel - Blood by Automated count
125
1135
3.63
2.81
35.5
11.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
6
8.60
2.77
1.4
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
6
8.60
2.77
1.2
2.5
—
—
—
0
0
(3036489) Thrombin time
11
38
3.07
2.65
1.7
1.7
s
21.5
20.3
0.33
11
33
(3045424) Erythrocytes [Presence] in Urine
7
15
4.87
2.63
2.3
1.1
—
—
—
0
0
(3010421) pH of Blood
9
25
3.79
2.63
10.6
2.3
ph
7.4
7.4
—
9
20
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
44
2.90
2.62
12.0
21.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
50
2.78
2.62
1.5
1.3
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
8
20
4.19
2.61
9.9
2.3
kpa
9.5
9.0
—
8
20
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
20
4.19
2.61
1.1
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
108
918
2.04
2.44
8.9
5.0
mmol/mol
39.9
39.1
0.34
101
860
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
22
3.80
2.40
1.3
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
22
3.80
2.40
1.4
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
27
151
1.99
2.39
2.4
1.6
nmol/l
1347.3
1243.1
0.24
21
113
(40761536) Microorganisms panel - Urine sediment
18
87
2.24
2.30
11.1
3.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
42
2.77
2.25
1.5
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
9
5.72
2.23
1.4
1.2
iu/ml
658.3
110.8
—
5
9
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
30
3.14
2.19
2.7
2.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
19
3.83
2.18
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
31
3.04
2.12
4.3
2.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
44
299
1.71
2.10
2.0
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
10
5.15
2.09
1.2
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
10
5.15
2.09
1.8
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
15
70
2.29
2.07
1.5
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
18
92
2.11
2.02
2.4
3.0
u/l
49.4
28.0
1.29
18
80
(3002179) Metamyelocytes/100 leukocytes in Blood
15
71
2.26
2.01
3.1
3.8
%
0.2
0.4
—
5
19
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
16
3.88
1.96
1.2
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
16
3.88
1.96
1.2
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
16
3.88
1.96
1.7
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
22
123
1.95
1.95
1.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
22
3.30
1.91
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
109
955
1.88
1.88
6.0
3.6
mmol/l
1.5
1.3
1.08
103
884
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
17
3.65
1.86
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
12
4.29
1.84
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
147
0.38
1.78
1.2
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
36
2.61
1.78
1.4
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
112
995
1.91
1.77
6.5
3.9
mmol/l
1.3
1.4
1.90
106
923
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
24
3.02
1.75
1.4
1.5
—
—
—
0
0
(3020891) Body temperature
10
42
2.50
1.72
6.5
4.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
112
998
1.88
1.71
6.6
3.9
mmol/l
4.6
4.6
0.15
106
931
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
19
3.26
1.68
1.7
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
43
2.44
1.65
10.6
3.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
49
362
1.57
1.63
4.4
3.6
ng/l
41.4
35.4
0.17
42
214
(3021960) Folate [Moles/volume] in Serum or Plasma
30
196
1.69
1.62
1.8
1.5
nmol/l
17.0
21.3
1.00
30
167
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
64
2.15
1.60
1.3
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
20
3.09
1.60
2.5
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
20
3.09
1.60
1.5
1.5
—
—
—
0
0
(4035726)
14
72
2.06
1.55
1.4
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
19
110
1.85
1.53
1.9
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
37
2.54
1.51
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
37
2.54
1.51
1.4
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
33
226
1.62
1.49
2.1
1.8
mg/l
0.9
1.3
0.50
26
180
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
20
119
1.80
1.48
13.9
8.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
22
2.81
1.45
5.5
4.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
16
3.21
1.45
1.6
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
16
3.21
1.45
1.6
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
27
177
1.66
1.44
4.5
2.8
ng/l
627.0
308.5
0.21
19
116
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
26
172
1.64
1.34
1.1
1.3
iu/ml
18.4
31.4
—
6
51
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
86
738
1.49
1.31
4.4
3.1
u/l
64.6
46.8
1.14
81
705
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
18
2.85
1.29
1.8
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
25
2.47
1.26
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
25
2.47
1.26
1.5
1.5
—
—
—
0
0
(3013512) EKG study
31
220
1.54
1.20
5.1
3.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
26
2.37
1.20
1.0
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
41
2.01
1.11
2.0
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
32
2.25
1.10
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
18
114
1.67
1.09
1.3
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
34
2.12
1.04
1.1
1.1
—
17.6
—
0
6
(3044889) 12 lead EKG panel
79
685
1.39
1.02
3.6
3.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
111
1026
1.56
0.98
33.1
12.7
%
38.1
40.6
2.26
81
816
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
37
1.94
0.95
1.4
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
41
322
1.40
0.95
1.6
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
162
1.51
0.92
1.4
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
64
1.79
0.89
4.3
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
106
977
1.46
0.88
6.7
3.9
mmol/l
5.8
5.8
0.08
98
897
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
72
1.73
0.88
1.4
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
48
1.71
0.80
1.6
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
34
1.80
0.77
1.8
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
34
1.80
0.77
1.3
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
23
2.22
0.77
1.0
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
39
1.84
0.74
2.6
2.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
46
387
1.29
0.66
2.1
1.9
—
—
—
0
0
(1002224) Polysomnography panel
8
49
1.67
0.63
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
24
186
1.36
0.60
2.7
1.9
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
53
1.54
0.59
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
23
0.00
0.59
0.0
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
88
810
1.27
0.58
4.1
3.7
—
—
—
0
0
(3000492) Spirometry study
15
108
1.44
0.56
1.4
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
11
78
1.45
0.44
2.1
2.5
—
7.7
—
0
5
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
205
0.75
0.44
1.9
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
95
0.61
0.44
1.5
2.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
33
1.54
0.42
1.6
2.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
34
1.49
0.41
1.4
1.9
—
—
—
0
0
(4034850)
5
36
1.40
0.38
16.6
15.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
10
73
1.40
0.35
1.3
1.3
—
20.1
—
0
5
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
45
1.35
0.34
2.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
43
385
1.17
0.33
3.5
2.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
33
290
1.18
0.31
1.3
1.3
u/ml
0.9
1.3
—
10
79
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
119
0.74
0.29
1.3
2.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
73
0.67
0.27
1.0
1.0
—
—
—
0
0
(4010399)
9
73
1.25
0.26
1.6
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
10.2
—
1220.8
—
0
10
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
10
0.00
0.21
0.0
1.6
—
13.4
—
0
10
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
8.2
—
751.4
—
0
10
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
10.0
—
0.6
—
0
10
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
111
0.80
0.21
1.2
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.3
—
3.6
—
0
13
(3023410) Appearance of Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
30
271
1.14
0.20
3.7
4.2
%
24.9
21.5
0.43
16
122
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
70
0.70
0.17
1.8
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
70
0.70
0.17
1.2
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
92
1.21
0.16
1.5
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
20
219
0.90
0.12
1.8
2.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
19
173
1.12
0.11
1.6
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
53
1.14
0.09
1.2
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
57
1.06
0.08
2.0
2.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
117
1.12
0.08
2.3
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
62
0.80
0.08
1.0
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
82
805
1.05
0.06
3.8
3.6
pmol/l
14.9
14.6
0.59
73
733
(3003338) MCHC [Mass/volume]
96
972
0.95
0.05
42.7
16.0
g/l
331.5
333.9
1.80
96
966
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
107
0.93
0.02
1.9
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
19
194
0.98
0.00
2.5
2.8
ug/l
0.7
0.7
0.07
13
115
(3022145) Colonoscopy Study observation
11
107
1.03
0.00
1.3
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
75
0.93
0.00
1.1
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
75
0.93
0.00
1.1
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
73
0.96
0.00
1.1
1.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.3
—
0
6
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.2
—
1.2
—
0
6
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
5.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(4024509)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
4.8
—
199.8
—
0
6
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
24.6
—
0
6
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
8.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(4198724)
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
6.4
—
196.6
—
0
8
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
51.4
—
0
7
(3018133) Calcium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
6.0
—
2.4
—
0
5
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
168.8
—
0
5
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
5.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
127.0
—
0
6
(3026389) Candida sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
238.4
—
0
5
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
1.5
—
0
5
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
51
0.98
0.00
1.6
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
15.3
—
0
8
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
74
0.94
0.00
1.1
1.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint N14_HENOCHSCHONLEIN_NEPHRITIS and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
N14_HENOCHSCHONLEIN_NEPHRITIS 2.718 [1.97, 3.75] < 0.001
Birth year 0.982 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 90 out of 588 males with N14_HENOCHSCHONLEIN_NEPHRITIS died.

Mortality risk

Mortality risk for people of age

years, who have N14_HENOCHSCHONLEIN_NEPHRITIS.

N-year risk Females Males
1 No data 0.508%
5 No data 2.64%
10 No data 6.883%
15 No data 12.352%
20 No data 20.208%

Relationships between endpoints

↥

Index endpoint: N14_HENOCHSCHONLEIN_NEPHRITIS – Henoch-Schönlein purpura nephritis (HSPN)

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data